FDA approves new stool collection kit of Geneoscopy’s CRC screening test
July 25, 2025
The test employs advanced RNA technology to identify biomarkers for colorectal cancer and advanced adenomas.
The test employs advanced RNA technology to identify biomarkers for colorectal cancer and advanced adenomas.
Designed for near-patient use, the test operates on an improved version of MeMed’s current platform.
Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates
Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body.
Researchers from Columbia Engineering have established a framework for the design of bioactive injectable hydrogels formulated with extracellular vesicles (EVs) for tissue engineering and regenerative medicine applications.